Literature DB >> 21791548

The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS.

Michele M Maxwell1, Elizabeth M Tomkinson, Johnathan Nobles, John W Wizeman, Allison M Amore, Luisa Quinti, Vanita Chopra, Steven M Hersch, Aleksey G Kazantsev.   

Abstract

Sirtuin 2 (SIRT2) is one of seven known mammalian protein deacetylases homologous to the yeast master lifespan regulator Sir2. In recent years, the sirtuin protein deacetylases have emerged as candidate therapeutic targets for many human diseases, including metabolic and age-dependent neurological disorders. In non-neuronal cells, SIRT2 has been shown to function as a tubulin deacetylase and a key regulator of cell division and differentiation. However, the distribution and function of the SIRT2 microtubule (MT) deacetylase in differentiated, postmitotic neurons remain largely unknown. Here, we show abundant and preferential expression of specific isoforms of SIRT2 in the mammalian central nervous system and find that a previously uncharacterized form, SIRT2.3, exhibits age-dependent accumulation in the mouse brain and spinal cord. Further, our studies reveal that focal areas of endogenous SIRT2 expression correlate with reduced α-tubulin acetylation in primary mouse cortical neurons and suggest that the brain-enriched species of SIRT2 may function as the predominant MT deacetylases in mature neurons. Recent reports have demonstrated an association between impaired tubulin acetyltransferase activity and neurodegenerative disease; viewed in this light, our results showing age-dependent accumulation of the SIRT2 neuronal MT deacetylase in wild-type mice suggest a functional link between tubulin acetylation patterns and the aging brain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791548      PMCID: PMC3203628          DOI: 10.1093/hmg/ddr326

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  47 in total

1.  Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle.

Authors:  Sylvia C Dryden; Fatimah A Nahhas; James E Nowak; Anton-Scott Goustin; Michael A Tainsky
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

2.  Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation.

Authors:  Jim P Dompierre; Juliette D Godin; Bénédicte C Charrin; Fabrice P Cordelières; Stephen J King; Sandrine Humbert; Frédéric Saudou
Journal:  J Neurosci       Date:  2007-03-28       Impact factor: 6.167

3.  The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms.

Authors:  M Kaeberlein; M McVey; L Guarente
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

4.  Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model.

Authors:  Luisa Quinti; Vanita Chopra; Dante Rotili; Sergio Valente; Allison Amore; Gianluigi Franci; Sarah Meade; Marta Valenza; Lucia Altucci; Michele M Maxwell; Elena Cattaneo; Steven Hersch; Antonello Mai; Aleksey Kazantsev
Journal:  PLoS Curr       Date:  2010-09-02

Review 5.  The Sir2 family of protein deacetylases.

Authors:  Gil Blander; Leonard Guarente
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

Review 6.  Ageing and neuronal vulnerability.

Authors:  Mark P Mattson; Tim Magnus
Journal:  Nat Rev Neurosci       Date:  2006-04       Impact factor: 34.870

Review 7.  Sirtuins in mammals: insights into their biological function.

Authors:  Shaday Michan; David Sinclair
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

8.  SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction.

Authors:  Fei Wang; Margaret Nguyen; F Xiao-Feng Qin; Qiang Tong
Journal:  Aging Cell       Date:  2007-05-23       Impact factor: 9.304

9.  Proteolipid protein is required for transport of sirtuin 2 into CNS myelin.

Authors:  Hauke B Werner; Katja Kuhlmann; Siming Shen; Marina Uecker; Anke Schardt; Kalina Dimova; Foteini Orfaniotou; Ajit Dhaunchak; Bastian G Brinkmann; Wiebke Möbius; Lenny Guarente; Patrizia Casaccia-Bonnefil; Olaf Jahn; Klaus-Armin Nave
Journal:  J Neurosci       Date:  2007-07-18       Impact factor: 6.167

10.  Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration.

Authors:  Claire L Simpson; Robin Lemmens; Katarzyna Miskiewicz; Wendy J Broom; Valerie K Hansen; Paul W J van Vught; John E Landers; Peter Sapp; Ludo Van Den Bosch; Joanne Knight; Benjamin M Neale; Martin R Turner; Jan H Veldink; Roel A Ophoff; Vineeta B Tripathi; Ana Beleza; Meera N Shah; Petroula Proitsi; Annelies Van Hoecke; Peter Carmeliet; H Robert Horvitz; P Nigel Leigh; Christopher E Shaw; Leonard H van den Berg; Pak C Sham; John F Powell; Patrik Verstreken; Robert H Brown; Wim Robberecht; Ammar Al-Chalabi
Journal:  Hum Mol Genet       Date:  2008-11-07       Impact factor: 6.150

View more
  67 in total

1.  SIRT2 Plays Significant Roles in Lipopolysaccharides-Induced Neuroinflammation and Brain Injury in Mice.

Authors:  Ban Wang; Youjun Zhang; Wei Cao; Xunbing Wei; James Chen; Weihai Ying
Journal:  Neurochem Res       Date:  2016-06-27       Impact factor: 3.996

2.  RNA-binding Protein Quaking Stabilizes Sirt2 mRNA during Oligodendroglial Differentiation.

Authors:  Merlin P Thangaraj; Kendra L Furber; Jotham K Gan; Shaoping Ji; Larhonda Sobchishin; J Ronald Doucette; Adil J Nazarali
Journal:  J Biol Chem       Date:  2017-02-10       Impact factor: 5.157

3.  Sirt2 Regulates Radiation-Induced Injury.

Authors:  Phuongmai Nguyen; Sudhanshu Shukla; Ryan Liu; Gopal Abbineni; DeeDee K Smart
Journal:  Radiat Res       Date:  2019-03-05       Impact factor: 2.841

Review 4.  The controversial world of sirtuins.

Authors:  Weiwei Dang
Journal:  Drug Discov Today Technol       Date:  2014-06

5.  MicroRNA-7 inhibits neuronal apoptosis in a cellular Parkinson's disease model by targeting Bax and Sirt2.

Authors:  Shize Li; Xuecheng Lv; Kaihua Zhai; Ruyan Xu; Yong Zhang; Songyao Zhao; Xiaoming Qin; Liujie Yin; Jiyu Lou
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

6.  Increased expression of SIRT2 is a novel marker of cellular senescence and is dependent on wild type p53 status.

Authors:  Tarique Anwar; Sanjeev Khosla; Gayatri Ramakrishna
Journal:  Cell Cycle       Date:  2016-05-26       Impact factor: 4.534

7.  Early sirtuin 2 inhibition prevents age-related cognitive decline in a senescence-accelerated mouse model.

Authors:  Teresa Diaz-Perdigon; Francisco B Belloch; Ana Ricobaraza; Elghareeb E Elboray; Takayoshi Suzuki; Rosa M Tordera; Elena Puerta
Journal:  Neuropsychopharmacology       Date:  2019-08-30       Impact factor: 7.853

8.  SIRT2 interacts with β-catenin to inhibit Wnt signaling output in response to radiation-induced stress.

Authors:  Phuongmai Nguyen; Sunmin Lee; Dominique Lorang-Leins; Jane Trepel; DeeDee K Smart
Journal:  Mol Cancer Res       Date:  2014-05-27       Impact factor: 5.852

9.  Loss of NAD-Dependent Protein Deacetylase Sirtuin-2 Alters Mitochondrial Protein Acetylation and Dysregulates Mitophagy.

Authors:  Guoxiang Liu; Seong-Hoon Park; Marta Imbesi; William Joseph Nathan; Xianghui Zou; Yueming Zhu; Haiyan Jiang; Loukia Parisiadou; David Gius
Journal:  Antioxid Redox Signal       Date:  2016-09-08       Impact factor: 8.401

10.  The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse models.

Authors:  Vanita Chopra; Luisa Quinti; Jinho Kim; Lorraine Vollor; K Lakshmi Narayanan; Christina Edgerly; Patricia M Cipicchio; Molly A Lauver; Soo Hyuk Choi; Richard B Silverman; Robert J Ferrante; Steven Hersch; Aleksey G Kazantsev
Journal:  Cell Rep       Date:  2012-11-29       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.